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INTRODUCTION 
Mitochondria: Origin and function 
The mitochondrion is a double-membraned organelle found in most eukaryotic cells, 
including plants, fungi, protists and animals. The two membranes comprise all 
components required for cellular mitochondrial function and have distinct structural 
properties. While the outer mitochondrial membrane (OMM) is rather permeable, 
allowing the free diffusion of small proteins and contains specialized channels for import 
of larger proteins, the inner mitochondrial membrane (IMM) is highly impermeable. 
Additionally, the IMM has a characteristic folding morphology which forms cristae. 
Between the two membranes is the intermembrane space, and enclosed by the IMM the 
mitochondrial matrix is formed (Zorov et al. 2009). The mitochondria contain their own 
mitochondrial DNA (mtDNA) which encodes a subset of proteins essential for the 
oxidative phosphorylation system, being the pathway to use redox energy via membrane 
potential for adenosine triphosphate (ATP) production. The electron transport chain 
(ETC), embedded in the IMM, utilizie the process of oxidative phosphorylation to 
produce ATP. The generation of cellular energy, in form of ATP is the main function of 
the organelle (Burger et al. 2003; Liu and O'Rourke 2009; Mitchell and Moyle 1979). 
However, the mitochondrion also participates in calcium homeostasis, heat production, 
cell-signaling and initiation of apoptosis.  
According to the endosymbiotic theory, the formation of the mitochondrion is believed to 
be a key event in the origination of the eukaryotic cell. mtDNA share common features 
with DNA from prokaryotes, thus a fusion event between an anaerobic host organism and 
a prokaryote is considered to be a crucial step in the evolution of eukaryotic cells (Gray et 
al. 1999). 
All proteins required for mtDNA replication, transcription and translation are encoded in 
genes in the nucleus. During the course of time, a number of mitochondrial genes have 
been relocated to the nuclear genome. However, some genetic material is kept within the 
mitochondrion and several reasons are proposed for preserving a separate mitochondrial 
genome. Hydrophobic proteins are difficult to import across mitochondrial membranes 
and are therefore produced within the mitochondrion (Falkenberg et al. 2007). In 
addition, the code-usage in mtDNA differs from the universal code in the nucleus. 
Finally, the assembly of mtDNA encoded subunits in the ETC is rate-limiting and by 
preserving a mitochondrial genome the subunits are transcribed when needed and occur 
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independently of the total mitochondrial population (Scheffler 2001; Falkenberg et al. 
2007). 
 
 
Figure 1: An overview graphic of the mitochondrial organelle divided into distinct compartments 
as defined by the outer and inner membranes. (Adapted with permission from Florida State 
University, http://micro.magnet.fsu.edu/cells/mitochondria/mitochondria.html) 
 
Electron transport chain and ATP production  
In the cell, carbon nutrients (like glucose) are utilized by catalytic processes (e.g. 
glycolysis and the citric acid cycle) to produce energy-rich conjugates like NADH and 
FADH. The oxygen-independent glycolysis is located in the cytosol and catabolize 
glucose into pyruvate.  Pyruvate is then converted to Acetyl-CoA in an oxidative 
decarboxylation reaction, and the formed NADH is further oxidized in the stepwise 
catabolizing citric acid cycle inside the mitochondrion. The cycle is allosterically 
regulated by NADH and other reaction intermediates like pyruvate and oxaloacetate. 
Lack of cellular oxygen will increase NADH concentrations which will inhibit citric acid 
cycle. From the citric acid cycle the net energy gain is 3 NADH and 1 FADH, which are 
subsequently used as electron donors in the ETC. Four enzyme complexes that reside in 
the IMM constitute the ETC. By means of serial redox reactions in the ETC, oxygen is 
reduced to water and an electrochemical gradient is established across the IMM.  The 
energy provided by this gradient is utilized by ATP synthase to generate ATP via 
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phosphorylation of adenosine diphosphate (ADP) (CHANCE and WILLIAMS 1956; 
Mitchell et al. 1979).  
The four ETC enzyme complexes are: NADH:ubiquinone oxidoreductase (complex I), 
succinate:ubiquinone oxidoreductase (complex II), ubiquinol:cytochrome C oxireductase 
(complex III) and cytochrome C: O2 oxidoreductase (complex IV). NADH and FADH2 
are oxidized by complex I and complex II, respectively. Electrons from NADH and 
FADH2 are transferred to complex III via ubiquinol: one out of two mobile electron 
carriers. The other electron carrier, cytochrome C (cyt C), is reduced by complex III, re-
oxidized by complex IV and oxygen is reduced into water. As a result of the redox-
reactions in complex I, III and IV, protons are translocated across the membrane, creating 
an electrochemical gradient. The flow of protons back from the intermembrane space into 
the matrix is coupled to the synthesis of ATP via the ATP synthase (Mitchell and Moyle 
1979; Mitchell et al. 1979) 
The individual respiratory complexes physically interact with each other to form 
supercomplexes. Different compositions of supercomplexes exist in the membrane and 
the ratio of components is proposed to facilitate the stability of the supercomplexes 
(Vonck and Schafer 2009).  
 
The mitochondrial DNA 
The mitochondrial genome is double-stranded, circular and consist of approximately 
16 600 base pairs (bp) in human cells and 16 300 bp in mouse cells. The mtDNA encodes 
two ribosomal RNAs, 22 transfer RNAs and 13 of the approximately 90 proteins present 
in the respiratory chain of the mammalian mitochondria (Falkenberg et al. 2007). The 
two mtDNA strands are termed heavy (H) and light (L) strand according to their guanine 
content, leading to a distinct separation on a cesium chloride density gradient. In contrast 
to nuclear genes, the mtDNA is compact with no or little intergenic regions. The only 
noncoding sequence is the noncoding region, which harbors gene elements required for 
regulation of transcription and replication that are recognized by specific transcription 
factors.  
The number of mtDNA copies in one mitochondrion is in the range of two to ten 
(Smeitink et al. 2001). mtDNA molecules are organized in structural units termed 
nucleoides, which are connected to the IMM (Garrido et al. 2003). Proteins active in a 
variety of dynamic processes, like replication and transcription, are associated with the 
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nucleoid structure. The mitochondrial transcription factor (TFAM), single stranded DNA 
binding protein (mtSSB), the mitochondrial helicase TWINKLE, mtRNA polymerase 
(POLMRT) and mtDNA polymerase γ (POLγ) are some of the proteins associated to the 
nucleoid structure (Wang and Bogenhagen 2006; Bogenhagen et al. 2003).   
mtDNA is maternally inherited, while mitochondria from the sperm are degraded upon 
fertilization (Sutovsky et al. 1999). However, the exclusion of paternal components is not 
absolute.  
 
 
Figure 2: The human mitochondrial DNA molecule. (Adapted with permission from (Bellance et 
al. 2009)). 
  
Replication of mtDNA 
Replication of the mitochondrial genome, in contrast to the replication of nuclear DNA, 
occurs independently of the cell cycle. Maintenance of an adequate mtDNA copy number 
is crucial in order to preserve functional mitochondrial activity and cell growth. Both 
high and low mtDNA copy numbers are associated with negative alterations in 
mitochondrial function and/or mtDNA. Several actors, like TWINKLE, Peroxisome 
11 
 
Proliferator-activated Reseptor γ Coactivator-1 alpha (PGC-1α) and TFAM, have been 
shown to function as control mechanisms for mtDNA number in the mitochondrion 
(Ylikallio et al. 2010; Scarpulla 2002; Jeng et al. 2008). Polymerase γ (POLγ) is encoded 
in the nucleus and is the only mtDNA polymerase identified (Spelbrink et al. 2000). 
Together with POLγ, mtSSB and TWINKLE represent the minimal components required 
for replication at the leading strand in mtDNA (Falkenberg et al. 2007).  Based on the 
presence of ribonucleotides in closed circular mtDNA and analysis of single stranded 
mtDNA replicative intermediates, a strand-displacement model was hypothesized, as 
reviewed in Clayton, 1982 (Clayton 1982). In this model, H and L strand replication 
starts from two distinct origins. H strand replication starts from the H-strand DNA 
replication origin (OH) and proceeds in the leading direction until two third of the H 
strand is synthesized. At this point, the origin for the L strand, L-strand DNA replication 
origin (OL), is exposed and synthesis of the L strand starts and continues in the opposite 
direction until both strands are replicated.   However, new data obtained from two-
dimensional agarose gel electrophoreses studies of replication intermediates suggest 
another model, in which conventional leading and lagging strand replication with 
multiple bidirectional replication forks takes place (Bowmaker et al. 2003).  
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Figure 3: Asynchronous method of replication. a) Replication of mtDNA begins in the D loop at 
the OH, displacing the light strand from the heavy strand. The light strand is single stranded until 
synthesis of the nascent heavy strand exposes OL.  At this point, replication of the light strand 
begins in the opposite direction until both strands have been fully replicated. b) Synchronous or 
coupled replication. In the suggested coupled replication model, replication begins from a zone 
of replication (OriZ) on the genome and replicates initially bidirectionally via conventional 
coupled leading- and lagging-strand synthesis. (Adapted with permission from Nature 
Publishing Group (Copeland and Longley 2008). 
 
 
Transcription of mtDNA 
There are two main transcription promoters in the mtDNA. Transcription from the light 
strand promoter (LSP) produces short mRNA molecules, which serves as primers for 
initiation of DNA synthesis at the origin of the H strand (Chang and Clayton 1985; 
a) 
b) 
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Falkenberg et al. 2007). Transcription from the H strand is initiated at two different 
promoter sites, H1 and H2. H1 produces a short rRNA transcript, and from H2 a 
polycistronic molecule is synthesized and further processed to yield mRNA-, tRNA- and 
rRNA-molecules. A mitochondrion specific RNA polymerase, POLRMT, is responsible 
for transcription of the mitochondrial genes (Yaginuma et al 1982). POLRMT requires 
assistance from the TFAM and one of the two mitochondrial transcription factors, 
TFB1M or TFB2M, to interact with the promoter and initiate transcription(Falkenberg et 
al. 2007). A family of mitochondrial transcription termination factors (mTERF 1-4) is 
suggested to be involved in termination of transcription, with mTERF3 as a negative 
regulator of mammalian mtDNA transcription (Park et al. 2007). 
TFAM is an important component in both transcription and replication. TFAM is 
associated with mtDNA and present in such large amounts in the mitochondria that the 
protein is able to cover the entire mtDNA (Kanki et al. 2004). The protein has also been 
shown to be important to maintain a stable mtDNA number with copy number correlating 
to the levels of TFAM (Ekstrand et al. 2004). Furthermore, TFAM may play a role in 
suppression of damaged mtDNA by binding preferably DNA with 8-oxoguanine (8-
oxoG) damage (Yoshida et al. 2002; Canugovi et al. 2010). Additionally, TFAM is 
present in nucleoids together with BER proteins and is believed to play an active role in 
the response to mtDNA damage (Kanki et al. 2004).  
 
 
Vulnerability of the mitochondrial DNA  
Environmental agents such as UV light, ionizing radiation and genotoxic chemical 
compounds might alter the chemical properties of the DNA molecule. The other main 
source of DNA damage is byproducts from normal cellular metabolism, especially 
reactive oxygen species (ROS). It is demonstrated that mtDNA is more susceptible to 
oxidative stress compared to nuclear DNA (de Souza-Pinto et al. 2001; Richter et al. 
1988). This vulnerability is suggested to be caused by its binding to the inner 
mitochondrial membrane, where oxidants are formed, and because of the lack of 
protective histones. A recent study demonstrate that histones are present in the 
mitochondrial membrane but not directly bound to the mtDNA (Choi et al. 2011). 
However, some degree of protection might be provided by TFAM which binds to 
mtDNA (Alam et al. 2003; Kanki et al. 2004). 
14 
 
Reactive oxygen species and mutagenic potential 
ROS production is a byproduct of aerobic respiration in the mitochondria. Oxidative 
damage caused by ROS is associated with disease and is a hallmark of aging. Oxygen 
reacts with electrons from energy rich reactions such as the ETC and can produce 
superoxide anion radical (O2-). Superoxide anion is unstable, with a short half-life and is 
normally detoxified by conversion to H2O2 by dismutases. Hydrogen peroxide is more 
stable than superoxide and is able to diffuse through the mitochondrial membrane. The 
toxic effect of peroxide stems from its ability to form the highly reactive hydroxyl radical 
(OH·) in the presence of divalent metal ions (Fe, Cu, Co or Ni). This radical is suspected 
to cause the most detrimental effects in mtDNA (Adam-Vizi and Chinopoulos 2006; 
Andreyev et al. 2005). In addition, ROS can cause many types of oxidative damage to the 
DNA including DNA strand breaks, base modifications, DNA-protein cross linking and 
apuridine/apyrimidine sites (AP sites) (Bjelland and Seeberg 2003). Oxidative base 
modifications include formamidopyrimidines (faPy-A), which is a ring-opened adenine, 
and faPy-G, which is a ring-opened guanine lesion. Other well known oxidative 
modifications are bases with retained aromaticity which have potential mispairing 
properties. Among the four DNA bases guanine has the lowest oxidation potential and is 
therefore the most easily oxidized base (Kovacic and Wakelin 2001). 8-oxoG is the most 
commonly used marker for DNA damage (Bjelland and Seeberg 2003).  
The mutagenic potential of oxidative lesions is illustrated in repair defective strains of 
Escherichia coli (E.coli), Saccharomyces cereveisia (S.cerevisiae) and mouse (Michaels 
and Miller 1992; Thomas et al. 1997; Asagoshi et al. 2000; Xie et al. 2004). In E.coli the 
repair system of oxidative damage is called the GO system and consists of MUTT, 
MUTM and MUTY, corresponding to the mammalian homologues MTH, OGG1 and 
MYH respectively. The power of the GO system to prevent mutagenesis is shown with 
the double deficiency of MUTM and MUTY demonstrating a synergistic effect in 
transversion mutations (Michaels and Miller 1992). For a lesion two prerequisites are 
necessary to cause mutations. First, the repair enzymes must fail to remove the damaged 
base before replication and, second, it must have different coding properties than the 
correct base.  8-oxoG will pair with adenine as frequently as with cytosine (Grollman and 
Moriya 1993) and if adenine is not removed prior to replication, adenine will be the 
template for thymidine in replication and lead to GC to TA transversions (Wood et al. 
1992; Moriya et al. 1991; Cheng et al. 1992). MUTT hydrolyses 8-oxoG from the 
nucleotide pool in E.coli. Mitochondria have their own pool of deoxynucleotide 
triphosphate (dNTPs), distinct from the larger nuclear dNTP pool (Marcelino and Thilly 
1999). The number of dNTPs in the mitochondrial pool is regulated separately from the 
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nuclear pool, probably because of the difference in replication control mechanisms of 
mitochondrial replication compared to nuclear replication (Clayton 2000). Oxidation of 
free nucleotides, like dUTP and 8-oxo2’-deoxyguanisin triphospate (8-oxo-dGTP) 
followed by incorporation into DNA contributes to mutations. The mammalian MYH is 
the major mechanism for the removal of premutagenic 8-oxo-dGTP from the dNTP pool 
(Nakabeppu 2001).  
 
The mitochondrial theory of aging and disease 
The mitochondrial theory of aging postulates that damage caused to mtDNA, proteins 
and lipids during the lifespan, leads to impaired mitochondrial function and aging of the 
organism (Harman 1981). An impaired electron transport chain can result in a negative 
feedback loop generating additional ROS. This additional ROS may erode mtDNA even 
further, giving rise to a secondary impairment of mitochondrial function. mtDNA damage 
is considered especially important in aging (Barja and Herrero 2000).  Normal aging is 
associated with declined mitochondrial functions, and a variety of diseases and 
pathological conditions like neurodegenerative disorders, diabetes and cancer are linked 
to mitochondrial dysfunction.  
The mitochondria participate in many different functions in the cell, and changes in 
mitochondrial function are detrimental to the cell. Alzheimer’s, Parkinson’s disease (PD) 
and Huntington’s disease (HD) are neurodegenerative diseases characterized by loss of 
neurons in the brain due to apoptotic cell death. Mitochondrial abnormalities have been 
found in neurodegenerative diseases and studies show accumulation of mtDNA damage 
in these diseases reflecting the importance of mtDNA maintenance (Jeppesen et al. 2011; 
Yang et al. 2008). The brain is dependent on glucose and has a high energy demand. 
Maintenance of the mitochondrial integrity for efficient ATP production is important to 
the brain, and loss of this function is strongly associated with neurodegeneration. It has 
been shown that neurons are highly sensitive to mitochondrial toxins, and disruption of 
the mitochondrial respiratory chain by such toxins leads to neuronal death and 
phenotypes that resembles PD and HD (Yang et al. 2008).  
Studies have shown that reduced food intake (caloric restriction) extend the lifespan in 
organisms such as yeast and rodents. In addition to extended lifespan, caloric restriction 
has shown to protect against diabetes, cancer and cardiovascular disease. Genetic 
alterations leading to decreased activity of nutrient-signaling pathways show the same 
protection against diseases and prolonging effect on lifespan (Fontana et al. 2010). 
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Several studies show that accumulation of oxidative damage in the DNA is reduced after 
caloric restriction (Heydari et al. 2007).  
To gain more insight into the contribution of mutations in mtDNA a mtDNA-mutator 
mouse expressing a defective mtDNA polymerase (POLγ) has been generated (Trifunovic 
et al. 2004). The proofreading activity of this mouse is reduced and this leads to an 
increase in somatic mtDNA point mutations. In line with the theory of aging, increasing 
amounts of mtDNA mutations cause a progressive respiratory chain deficiency, showing 
reduced life span and a premature aging phenotype of the mouse. No cancer is associated 
with the phenotype of this mouse. 
 
mtDNA mutagenesis: contributors 
Mutations in mtDNA are underlying factors in many mitochondrial diseases. 
Additionally, mtDNA mutations are found to be associated with neurodegenerative 
diseases, diabetes, cancer and aging. Mutations in mtDNA can arise from exposure to 
environmental mutagens, from unrepaired DNA damage, replication error in DNA 
synthesis and/or from defects in the mtDNA degrading system (Krokan et al. 1997). 
Since polγ is the only DNA polymerase found present in the mitochondria, polγ is most 
likely to be the responsible polymerase for replication errors leading to mutations.  The 
POLγ has a catalytic subunit that has DNA polymerase, 3’-5’ exonuclease and 5’ dRP 
lyase activities (Graziewicz et al. 2006). The fidelity of POLγ is high for nucleotide 
selectivity, exonucleolytic proofreading and for base incorporation in short, repetitive 
sequences. However, the frameshift fidelity of POLγ when copying homopolymeric 
sequences longer than four nucleotides is lower (Longley et al. 2001). A study claim that 
85 % of mutations detected in vivo are probably due to misincorporation by the 
mitochondrial polymerase (Zheng et al. 2006). There is no study that estimates how much 
DNA damage contributes to mutations in the mtDNA.  
Whether mutations arise mainly from replication errors inserted by POLγ or by 
unrepaired damage remain unclear.  
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Mitochondrial DNA repair 
Mitochondria have their own distinct repair systems which resemble the nuclear systems 
but are less complex. The mitochondrial genome does not encode repair proteins and 
thus, they are encoded by nuclear genes, and imported into the mitochondria. 
Mitochondrial proteins might differ from the nuclear versions by splice variation, post-
translational modification or alternative translation-initiation (de Souza-Pinto et al. 2008).  
 
Base excision repair in mitochondria 
The mitochondrial BER pathway is a multistep process for removal and replacing 
chemically altered bases, such as oxidized base lesions, in addition to repair of 
apurinic/apyrimidinic (AP) sites and single strand breaks. The repair pathway is 
evolutionally conserved and is initiated by different DNA glycosylases that recognize and 
excise specific base lesions. The remaining AP-site is processed by an AP endonuclease 
(APE1) prior to the action of POLγ filling the single nucleotide gap. The remaining nick 
is sealed by DNA ligase IIIa (Bogenhagen et al. 2001; Pinz and Bogenhagen 1998; de 
Souza-Pinto et al. 2008).  These four steps constitute the short-patch BER (SP-BER). In 
addition, activity of Long-patch BER (LP-BER) has been detected in mitochondrial 
extracts (Liu et al. 2008a). From the gap-filling step the BER pathway can be sub-divided 
into SP- and LP-BER. While in SP the polymerase fills the single nucleotide gap, the LP 
performs a repair synthesis of several nucleotides (2-13). The replaced nucleotides are 
removed by the flap endonuclease 1, FEN1, whose activity is stimulated by proliferating 
cell nuclear antigen (PCNA) (Szczesny et al. 2008; Liu et al. 2008b). Both FEN1 and 
DNA2, a mitochondrial nuclease/helicase needed for LP, are found in the mitochondria 
(Szczesny et al. 2008; Zheng et al. 2008). The discovery of LP-BER in mitochondria is 
recent and additional studies are needed to determine the exact mechanism of this sub-
pathway.  
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Figure 4:  mtDNA base excision repair: An oxidized or damaged base is excised by a specific 
glycosylase, leaving an abasic site, after which APE1 generates a strand break 5′ to the lesion 
and a 5′deoxyribose phosphate group on the downstream DNA. Repair can proceed via the 
single nucleotide BER (SN-BER) pathway (left) or the LP-BER pathway (right). In SN-BER, the 
single-nucleotide gap is filled by POLγ and the 5′dRP moiety is removed by POLγ's dRP lyase 
activity to make a ligatable substrate. In LP-BER, DNA synthesis by POLγ displaces the 
downstream strand to produce a 5′flap structure, which can be processed by DNA2 and FEN1. 
(Adapted with permission(Krishnan et al. 2008)). 
 
DNA glycosylases are encoded in the nucleus and are actively transported to the 
mitochondria. Damaged bases recognized by DNA glycosylases are released from the 
sugar by breaking the N-glycosylic bond. The 8-oxoguanine DNA glycosylase (OGG1) 
and the endonuclease III homologues 1 (NTH1) are the main DNA glycosylases for 
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removal of the oxidized bases lesions from mtDNA like 8-oxoG and Fapy, respectively. 
The human OGG1 (hOGG1) exist in two spliceforms, the α- and β- hOGG1, with the β-
hOGG1 containing a mitochondrial localization signal. However, the β-HOGG1 exhibits 
no glycosylase activity and αhOGG1 is most likely participating in 8-oxoG incision in 
mitochondria (Hashiguchi et al. 2004). In addition to OGG1, endonuclease VIII like 
(NEIL1) removes faPy and is found in mitochondria (Hu et al. 2005). OGG1 is, together 
with NEIL1 and NTH1, bi-functional DNA glycoslyases with 3’AP lyase activity to 
perform single strand breaks in addition to the glycosylase activity. In mouse, NTH1 is 
mainly transported to mitochondria while the human NTH1 is mostly localized to the 
nucleus (Karahalil et al. 2003; Ikeda et al. 2002). Uracil DNA Glycosylase 1 (UNG1) 
removes uracil from DNA, a result either from a deaminated cytosine (Lindahl 1993) or a 
misincorporated dUMP instead of dTMP during replication (Krokan et al. 1997). 
Misincorporated adenine opposite 8-oxoG is recognized and removed by MYH, which is 
found to localize to the mitochondrial matrix (Takao et al. 1998).  
 
Other repair systems in mitochondria 
While BER is a multi-step repair pathway, direct repair is a single step process and does 
not involve breaking of the phosphodiester bond (Hakem 2008). The main direct repair 
protein, methyl guanine methyl transferase (MGMT), has not been found in 
mitochondria. However, some methyl-groups are repaired in mtDNA whereas for the 
more complex alkylation damage no repair has been detected (LeDoux et al. 1992). A 
photolyase protein capable of direct repair of ultra violet (UV) mtDNA damage is 
directed to mitochondria in S.cerevisiae (Yasui et al. 1992), while no photolyase activity 
is detected in mammalian cells.  
Mismatch repair (MMR) is a conserved DNA repair pathway for recognition and repair 
of misincorporated bases, insertions and deletions arising during DNA replication and 
recombination (Jiricny 2006) and thus, improving the fidelity of replication. Proteins 
participating in MMR have been detected in mitochondria from S.cerevisiae (Chi and 
Kolodner 1994), but not for mammalian mitochondria. However, low but significant 
MMR activity has been detected in mitochondrial extracts from rats. It is debated whether 
MSH2, a key MMR protein, is present in mitochondria and the findings that Y-box 
binding protein (YB-1), a multifunctional protein, participates in mitochondrial MMR, 
indicate a novel pathway distinct from the nuclear one (Mason et al. 2003; de Souza-
Pinto et al. 2009).  
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Double strand break (DSB) are induced by exogenous sources, like ionization radiation 
and intracellular sources, like ROS, during failure from replication and repair events 
(Larsen et al. 2005). DSBs are repaired by two distinct repair pathways in the nucleus: 
homologous recombination (HR) and non-homologous end-joining (NHEJ). In vitro 
studies indicate recombination activities of both pathways in mammalian mitochondrial 
extracts (Bacman et al. 2009; Fukui and Moraes 2009). Identification of proteins that 
binds double-stranded DNA ends in mammalian mitochondrial extracts support findings 
of recombination activity. However, the end-joining activity was independent of Ku70, a 
protein known to be involved in nuclear double-stranded DNA repair, suggesting that the 
mechanism is different from that of mitochondria (Coffey et al. 1999).   
 
Cockayne Syndrome group B protein in BER 
Cockayne Syndrome (CS) is a severe inherited disease characterized by premature aging 
and neurological impairment. The patients suffer from hearing loss, retarded growth and 
other symptoms that resemble accelerated aging (Nance and Berry 1992; Weidenheim et 
al. 2009; Licht et al. 2003). CS patients have a mutation in the CS complement group A 
(CSA) or B (CSB) protein, most commonly in CSB. These proteins are known to 
participate in DNA maintenance through transcription coupled repair (TC-NER) (Licht et 
al. 2003). In CS patients, TC NER is defective for the repair of UV induced cyclobutane 
pyrimidine dimers.  
The CSB gene encodes a 168 kDa protein (Troelstra et al. 1992) with homology to the 
SWI/SNF family of proteins. The CSB include an acidic region, a glycine rich region, 
two putative nuclear localization signal sequences, and an ATPase domain. The ATPase 
domain includes seven conserved ATPase motifs found in all SWI/SNF family proteins 
and supports DNA helicase activity. 
csbm/m cells accumulate oxidative mtDNA damage (Osenbroch et al. 2009; Stevnsner et 
al. 2008) and are defective in repair of 8-oxoG (Stevnsner et al. 2002). When ogg1 is 
additionally mutated a strong increase of oxidative damage accumulation is apparent 
(Osterod et al. 2002). Together, these results are strongly implying that CSB is involved 
in BER of oxidative lesions in genomic DNA and maybe mitochondrial DNA.  
In 2010, two distinct publications confirmed the presence of the CSB protein in 
mitochondria (Aamann et al. 2010; Kamenisch et al. 2010). CSB was demonstrated to 
localize to mitochondria, with increased mitochondrial distribution following oxidative 
stress induced by menadione (Aamann et al. 2010). In addition to mitochondrial 
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localization, CSB (and CSA) was found to form a complex with mtDNA, OGG1 and 
mtSSBP upon oxidative stress. The exact function of CSB in mitochondria and the 
connection to OGG1 is still unclear. It is hypothesized that CSB influences the 8-oxoG 
repair activity by regulating OGG1 expression and/or activity. This hypothesis is 
supported by the work of Dianov et al 1999 who report reduced OGG1 expression in  
csbm/m cells (Dianov et al. 1999) and by increased expression of OGG1 in CSB depleted 
cells retransfected with CSB (Stevnsner et al. 2002).  Elevated levels of mtDNA 
mutations were found in reduced subcutaneous fat tissue of aged mice with CSA or CSB 
deficiency. Reduced fat in subcutaneous tissue is a hallmark of aging and this correlates 
with a role of CSB (and maybe CSA?) in protecting DNA (Kamenisch et al. 2010) 
 
DNA maintenance and metabolic response 
In S.cerevisiae, mitochondrial metabolism via the protein Aconitase is involved in 
mtDNA maintenance (Chen et al. 2005). Mitochondrial Aconitase catalyses the 
isomerization of citrate to isocitrate in the citric acid cycle. This protein is sensitive to 
oxidative stress and it is readily used as a marker of oxidative stress (Bulteau et al. 2003). 
Aconitase has been found to interact with OGG1 independently of mtDNA repair, and a 
role of human OGG1 as a mitochondrial Aconitase chaperone has been postulated 
(Panduri et al. 2009). This action might be important in the defense against toxicity 
induced by oxidative damage. The yeast study demonstrates a new role of mitochondrial 
Aconitase (Chen et al. 2005). They found mitochondrial Aconitase to bind mtDNA and 
be crucial for DNA maintenance, thereby linking cellular metabolism to mtDNA 
maintenance (Chen et al. 2005). Furthermore, mitochondrial Aconitase is found to 
interact with the β-hOGG1 in lung epithelial cells (Panduri et al. 2009). By 
overexpressing a mutated α-hOGG1, with no glycosylase activity and with a 
mitochondrial translocation signal, mitochondrial dysfunction and apoptosis was 
prevented. The lack of glycosylase activity suggests a novel mechanism of OGG1 as a 
mitochondrial Aconitase chaperone protein that prevents mitochondrial dysfunction and 
apoptosis induced by oxidative damage. 
A mouse deficient in the NEIL1 DNA glycosylase show increased levels of mtDNA 
damage and deletions when compared to wild-type (Vartanian et al. 2006). In response to 
deficient DNA maintenance, the mouse develops severe obesity, dyslipidemia and fatty 
liver disease. Whether mtDNA damage is the cause of this metabolic syndrome or the 
consequence of nuclear DNA damage and disease are discussed by the authors (Vartanian 
et al. 2006). For further examination of the possible metabolic response to mtDNA 
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damage, the NEIL1 deficient mice were exposed to oxidative stress in the form of a high-
fat diet (Sampath et al. 2011). This greatly enhanced the development of obesity in 
NEIL1 deficient mice, in addition to a significant reduction in mtDNA and protein 
content. The authors propose that animals lacking NEIL1 are less tolerant of oxidative 
DNA damage and that deficient mtDNA maintenance leads to disease.  
The metabolic responses to oxidative mtDNA damage are complex and involve many 
processes. The nuclear transcription factor p53, a tumor suppressor gene involved in 
apoptosis in mitochondria, has been shown to induce cell arrest in response to DNA 
damage (Lakin and Jackson 1999). The Sirtuin family of deacetylases consists of seven 
proteins, some of them located in the mitochondria. Especially the SIRT1 is activated by 
the redox status in the mitochondria, more specifically by NADH (Alcain and Villalba 
2009). A study shows that the fate of neuronal progenitors is related to SIRT1 as a 
mediator of the redox status (Prozorovski et al. 2008). The expression of both p53 and 
SIRT1 is upregulated after oxidative stress (Lakin and Jackson 1999; Alcain and Villalba 
2009).  
Damage: discard or repair?  
Considering the multicopy nature of mtDNA it was originally believed that repair of 
mtDNA was unnecessary and the theory of mtDNA degradation in response to damage 
was therefore accepted. With time DNA repair systems have been demonstrated in 
mitochondria. 
Selective degradation of damaged DNA is shown in mitochondria.  A study by Mita and 
coworkers showed that the mitochondrial genome of HeLa cells accumulated few 
mutations in response to chemical carcinogens, suggesting that mtDNA contained large 
amounts of damaged DNA that was not replicated (Mita et al. 1988). Several studies have 
targeted site-specific restriction endonucleases to mitochondria as a mean to demonstrate 
that large amounts of double-strand breaks cause mtDNA degradation (Kukat et al. 2008; 
Bacman et al. 2009; Fukui and Moraes 2009), while low levels of DSBs lead to 
recombination (Bacman et al. 2009). Shokolenko and coworkers showed that extensive 
oxidative damage lead to degradation of mtDNA. Additionally, when APE1 activity is 
inhibited, the degradation of mtDNA is further enhanced (Shokolenko et al. 2009). It is 
speculated that DSB triggers mtDNA degradation, probably by forming a stalled complex 
with DNA or RNA polymerases on the damaged mtDNA template (Liu and Demple 
2010). Both strand breaks and AP sites lack coding information and it is important to 
repair or eliminate such damage to prevent mutagenesis. The process of degradation of 
damaged DNA is unique to the mitochondrial DNA.   
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AIMS 
Mitochondrial dysfunction is believed to be the underlying cause in many life-style 
diseases like diabetes, neurodegenerative diseases, cancer and DNA damage in general.  
Damage to the mitochondrial genome is thought to be the main factors leading to 
mitochondrial dysfunction. In this study, we aimed to use cellular models with apparent 
signs of mitochondrial dysfunction or, alternatively, deficiency in the mitochondrial DNA 
maintenance capacity, to study how damage to the mitochondrial genome manifest into 
mitochondrial or cellular dysfunction. The purpose was to evaluate the impact of mtDNA 
damage on the processes resulting in mitochondrial dysfunction.  
In addition to mtDNA damage, nuclear DNA damage, metabolic alterations and 
environmental toxins can result in mitochondrial dysfunction. In the present study we 
aimed to investigate how the contribution of mtDNA damage leads to mitochondrial 
dysfunction.  
Four different systems were used to assay this interaction: 
1) Mouse cells with a CSB truncated protein, mimicking the damage human disease 
Cockayne syndrome (CS), were used as a model. CS is a neurodegenerative 
progressive disorder which resembles a mitochondrial disease. The CSB protein is 
involved in DNA maintenance in the nucleus but has also been shown to 
participate in regulation of proteins with localization to mitochondria.  
2) Cells from genetically modified mice that were either deficient in the base 
excision repair (BER) (ogg1-/-), the nucleotide excision repair (NER) of UV 
induced damage (csbm/m), or both, were used in this study. By looking into mtDNA 
processes in these mutant cells the relative contribution of the two separate repair-
mechanisms in mtDNA could be estimated.  
3) Oxidative stress is formed naturally in the cell and is known to damage mtDNA. 
Aconitase is a protein participating in the citric acid cycle and is readily used as a 
marker of oxidative stress. Using the cell lines deficient in BER, (ogg1-/-) 
Aconitase was used to look into how metabolic changes interfere with the 
mitochondrial function.  
4) In order to investigate whether mtDNA damage leads to mutations we used a 
mouse deficient in two DNA glycosylases that is participating in BER (myh-/-
/ogg1-/-). OGG1 and MYH are known to localize both to nuclear and 
mitochondrial compartments.  
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SUMMARY OF PAPERS 
Accumulation of mitochondrial DNA damage and bioenergetic dysfunction in CSB-
defective cells 
Cockayne syndrome (CS) is a severe inherited human disease characterized by premature 
aging and neurodegeneration. The disease is caused by a mutation in the CSB gene, 
whose protein product is involved in transcription coupled repair of DNA in the nucleus. 
A csbm/m mouse model was utilized to investigate mitochondrial DNA damage in CSB-
defective cells.   
CS shares many clinical signatures associated with mitochondrial dysfunction, like 
developmental problems, neurodegeneration, muscular and skeletal defects, deafness, and 
premature aging as well as accumulation of oxidative DNA damage. In order to evaluate 
potential bioenergetic defects in csbm/m cells, we analyzed the sensitivity to inhibition of 
bioenergetic defects in these cells. Finally, mitochondrial function was evaluated by 
measuring the respiration capacity and electron transport chain (ETC) organization.  
We found that csbm/m cells were more sensitive than wt to all bioenergetic inhibitors, 
which is indicative of an energy-critical phenotype. While the sensitivity to rotenone, 
3NP, antimycin, KCN and oligomycin in general was stronger than in wt cells, the 
relative sensitivity to 2-deoxyglucose, an inhibitor of glycolysis, was especially 
prominent. This implies that the csbm/m cells are relatively dependent on glycolytic energy 
conversion. In association with the bioenergetic susceptibility, we identified altered 
organization of the ETC subunits into supercomplexes. These alterations correlated to 
some extent with the mitochondrial DNA (mtDNA) damage in that liver mtDNA from 
csbm/m accumulated more 8-oxoG and were less capable of being amplified by PCR than 
wt mtDNA. However, we could not directly couple mtDNA damage to the alterations in 
ETC organization, suggesting that the CSB protein is involved in both mtDNA and 
mitochondrial function. Our data indicate that mitochondrial dysfunction could be a 
possible underlying cause of Cockayne Syndrome.  
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Cellular sensitivity of Cockayne Syndrome B deficient cells to oxidative stress is 
mediated by 8-oxoguanine DNA glycosylase and is associated with inefficient 
mitochondrial transcription 
The study described above implies that CSB is involved in the maintenance of 
mitochondrial DNA (mtDNA). In the process of this PhD-project, another group 
demonstrated the presence of CSB in mitochondria and involvement in the base excision 
repair of 8-oxoG from mtDNA. In order to evaluate the impact of CSB in the 
maintenance of mtDNA, we used cells from genetically modified mice that were either 
deficient in base excision repair (ogg1-/-), nuclear transcription-coupled repair of UV-
induced DNA damage (csbm/m), or both, to study the relative contribution of OGG and/or 
CSB on mtDNA repair, as well as possible overlap. Since our work has demonstrated that 
CSB was additionally implicated in cellular function beyond mtDNA damage (paper I), 
we further investigated the impact on mtDNA damage on both cellular replication and 
transcription. Our results demonstrated that the mutant cells were sensitive to the 
mitochondrial oxidant menadione, in line with a function of OGG1 and CSB in repair of 
mtDNA. Interestingly, the phenotype of the cells indicates that CSB belongs to the same 
complementing group as OGG1 in the repair of oxidative damage, but not for the 
removal of UV-induced damage. Our data suggest that CSB functions downstream of 
OGG1 and facilitates efficient progression of repair intermediates. Interestingly, mtDNA 
damage was not specifically inhibiting mitochondrial replication but rather mitochondrial 
transcription.  This indicates that oxidative stress-induced mtDNA damage is particularly 
detrimental for mitochondrial transcription. Surprisingly, the mitochondrial transcription 
rate in mtDNA repair mutants is less than 10 % of that in wt cells, suggesting that 
spontaneously formed mtDNA damage have the potential to inhibit transcription if not 
repaired efficiently.  
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Novel regulation of citric acid cycle involves mitochondrial DNA repair 
Oxidative mtDNA damage is formed under conditions of oxidative stress. Such oxidative 
stress is also expected to modify cellular processes like intramitochondrial metabolic 
pathways. The function of mitochondrial Aconitase is to catalyze the isomerization of 
citrate to isocitrate in the citric acid cycle. It is one of the most sensitive enzymes to 
oxidative stress in the mitochondria, and it is readily used as a marker of oxidative stress. 
Interestingly, it has been found to interact with OGG1 independently of mtDNA repair. 
Here, we sought to understand the interplay between metabolism and mtDNA repair 
during and after oxidative stress. Our results suggest that the OGG1-Aconitase interplay 
represents a molecular link for regulating aerobic metabolism in a mtDNA-dependent 
manner. Hence, these results also demonstrate that mtDNA damage modifies 
mitochondrial function by regulating metabolic pathways inside the organelle.  
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Impact of mitochondrial DNA mutations in a DNA repair deficient mouse model 
with elevated carcinogenesis and shortened lifespan 
 
Reactive oxygen species (ROS) are formed as natural byproducts during aerobic 
metabolism. The 8-oxoG DNA glycosylase 1 (OGG1) and MutY homologue 1 (MYH1) 
are proteins participating in Base Excision Repair (BER) of DNA. Studies from E.coli 
have shown that deletions of both enzymes lead to a synergetic increase in G to T 
transversions in DNA. A mouse model deficient in OGG1 and MYH suffers from 
increased tumorigenesis and shortened lifespan.  Mitochondrial DNA (mtDNA) 
mutations have been linked to many forms of cancer. 
It has been shown that damage accumulates in nuclear DNA in the OGG/MYH double 
deficient animals, and our laboratory has shown that OGG1 is especially important for 
the removal of 8-oxoG from mtDNA. Since both OGG1 and MYH have shown 
localization to mitochondria, we hypothesized that accumulation of mtDNA damage 
could lead to mutations with age and, thus be manifested into mitochondrial dysfunction.  
Examination of tissue from both young and adult mice may indicate to what extent 
possible mitochondrial dysfunction was responsible for the increased carcinogenesis (and 
shortened lifespan) of these animals. Tissue (brain, lung and liver) from young and adult 
mice were analyzed for mtDNA damage and mutations. The function of the mitochondria 
from the different tissues was analyzed for comparison, as measured by the ability to 
generate large PCR products. Despite the absence of OGG1, we could not detect reduced 
mtDNA integrity in the repair double knockout mice except for in liver. Possibly, this is 
due to the fact that 8-oxoG, that is expected to accumulate, is not detected by this 
method. Surprisingly, we found no differences in mutation levels between knockout mice 
or wt and no accumulation of mutations with age.  In line with this data, mitochondrial 
function was normal in all tissues at both ages, except in brain, where we discovered a 
significant 25 % reduction in complex I activity and corresponding respiration capacity. 
We suspect that efficient backup mechanisms for removal of premutagenic 8-oxoG is 
responsible for the innocuous phenotype. 
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DISCUSSION  
Our aim was to look closer into the connection between mtDNA damage, mitochondrial 
dysfunction and aging/disease.   
 
mtDNA damage  
The influence of mtDNA damage was evaluated in cells that lack either OGG1 or CSB 
proteins. Thus, unrepaired mtDNA damage will alter processes that require these protein 
functions. By comparing phenotypes during different situations, we have compared 
impact of mtDNA damage on transcription, replication, mutagenesis and mitochondrial 
metabolism. Our data indicate that both OGG1 and CSB function in the base excision 
repair of mtDNA damage, independently of the nuclear role of the same proteins. 
Moreover, important differences in cells deficient in one or both of these functions 
indicate what processes that are associated with mtDNA maintenance. 
 
A function of CSB in mitochondria 
CSB in mtDNA repair 
The role of CSB in the repair of UV adducts via the nucleotide excision repair pathway 
has been known for some time (Balajee et al. 2000), and hypersensitivity to UV 
irradiation is a hallmark of the CS phenotype (Stevnsner et al. 2008). More recently, it 
was shown that extracts from csbm/m cells are deficient in repair of 8-oxoG (Dianov et al. 
1999). Additionally, Stevnsner and coworkers demonstrated a role of CSB in repair of 8-
oxoG in mitochondrial DNA (Stevnsner et al. 2002). The stimulation of repair was 
exclusive for 8-oxoG which is the substrate of OGG1 in the BER pathway. However, 
previous studies have shown that repair of 8-oxoG in the mitochondria involves only 
BER and not NER, in which CSB is known to participate (Anson et al. 1998). 
Furthermore, CSB has been found in the nucleus exclusively. By characterization of the 
csbm/m mice cells we found that they were sensitive to all inhibitors of mitochondrial 
complexes and especially to the inhibitor of glycolysis (Paper I). In addition, we show 
that csbm/m cells accumulate mtDNA damage, supporting a role of CSB in mtDNA 
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maintenance (Stevnsner et al. 2002). Furthermore, the csbm/m cells are sensitive to 
induced mitochondrial oxidative damage (PAPER II) in an OGG1-dependent manner. In 
sum these results imply a role of CSB in response to oxidative damage in mtDNA, which 
is independent of the nuclear function in nucleotide excision repair. For CSA, the other 
complement group protein causing Cockayne Syndrome, separate roles in response to UV 
and oxidative damage was found (Nardo et al. 2009).   In 2010 two studies report of CSB 
found in mitochondria (Kamenisch et al. 2010; Aamann et al. 2010). Both CSA and CSB 
were found to relocalize to mitochondria after exposure to oxidative stress. This is 
consistent with our and others result suggesting a role of CSB in processing mtDNA 
damage. Finally, the CS proteins were found in connection with OGG1 (Kamenisch et al. 
2010), demonstrating the CSB sensitivity in an OGG1-dependent manner (PAPER II). 
Our result, showing csbm/m sensitivity against menadione, coincides with the result of 
CSB to translocate to mitochondria in response to menadione (Aamann et al. 2010).  
We believe that CSB acts downstream of OGG1 in the BER pathway, a role independent 
of its function in the nucleotide excision repair. The exact mechanism of CSB in mtDNA 
repair is still unclear. It is suggested that CSB may act as a scaffold or organizing protein 
to connect the BER process to the mtDNA in the inner mitochondrial membrane 
(Aamann et al. 2010). It is also suggested that CSB is important to reduce the toxic effect 
of repair intermediates (PAPER II). CSB has been shown to stimulate the catalytic 
activity of apurinic endonuclease 1 (APE1),  and protect against toxic effects from APE1 
substrates (Wong et al. 2007). The exact mechanism for import of CSA and CSB into the 
mitochondria is not clear. However, since the CS proteins are relocalized in response to 
mtDNA damage, a functional role in processing these damages is clearly supported.  
 
CSB involvement in mitochondrial transcription  
Looking into cellular mechanisms we found that oxidative stress inhibits mtDNA 
replication similarly as nuclear DNA replication. For the mitochondrial transcription we 
found it to be inefficient in mutant cells compared to wt cells, indicating that repair of 
mtDNA is more important to facilitate efficient transcription rather than efficient mtDNA 
replication (PAPER II). CSB is also involved in controlling the levels of mitochondrial 
transcripts after oxidative stress (PAPER II). The influence of mtDNA repair on 
mitochondria transcription efficiency is a relatively unexplored field, and for CSB a 
connection to transcription is mainly due to findings in the nucleus, where it has been 
shown to bind to a fraction of the RNA polymerase II (RNA pol II) which catalyzes the 
transcription of DNA to synthesize precursors of mRNA, snRNA and micro RNA (van 
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Gool et al. 1997). Several models have been proposed regarding how CSB plays a role in 
the rescue of RNA pol II complexes that are stalled at oxidative DNA lesions, but the 
details remain unclear (Stevnsner et al. 2008; de et al. 2004). However, RNA pol II has 
not been found in mitochondria. 
The coexistence of TFAM in the nucleoid (Bogenhagen et al. 2003) might provide a 
molecular mechanism for how the mtDNA damage facilitates transcription arrest. TFAM 
is present at levels sufficient to cover mtDNA entirely and binds preferentially to 
branched DNA and mtDNA damage (Kanki et al 2004). Recently, TFAM was found to 
colocalize with CSB in response to oxidative stress in mitochondria (Aamann et al. 2010) 
supporting a role of CSB in transcription.  
 
CSB in ETC organization 
According to the mitochondrial theory of aging accumulated mtDNA damage could lead 
to impaired mitochondrial function. The respiration in csbm/m cells is normal, but the 
arrangement of respiration complexes into supercomplexes in the inner mitochondrial 
membrane is altered in csbm/m cells (PAPER I). The rearrangement of supercomplexes 
was not due to inhibition of transcription/replication, and might be related to a yet 
unidentified role of the CSB protein. In summary, these data implies a mitochondrial 
dysfunction as an underlying cause of Cockayne Syndrome. Reports of the presence of 
CSB protein in mitochondria strengthen the theory of mitochondrial influence in the 
pathology of Cockayne Syndrome (Aamann et al. 2010; Kamenisch et al. 2010). 
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OGG1 in mitochondria 
Impact of OGG1 in the repair of 8-oxoG 
An increase in oxidative damage in mitochondria does not give rise to increased mutation 
rates, at least not by the action of OGG1 (PAPER IV).  Possible back-up systems for 8-
oxoG lesions in mitochondrial DNA could be the DNA glycosylase NEIL1. A weak, but 
not significant excision activity towards 8-oxoG was detected (Jaruga et al. 2000). In 
HeLa cell a second OGG (OGG2) has been identified and partially characterized (Hazra 
et al. 1998). While OGG1 preferentially excise 8-oxoG opposite a guanine, the OGG2 
shows activity for 8-oxoG opposite guanine or adenine.  In addition, the same group 
found a DNA glycosylase with sequence homologue to MUTM (OGG1) and NEI, Nei 
homolog (NEH1) (Hazra et al. 2002). NEH1 show a weak activity for 8-oxoG: C and 
stronger activity for 8-oxoG: A activity, but the excision activity is stronger for FaPy 
lesion than 8-oxoG. None of these proteins have been detected in mitochondria. Finally, 
mismatch repair activity of single G-T and G-G mismatches has been detected in 
mitochondria and shown to contribute to remove oxidative lesions from mtDNA (Mason 
et al. 2003). If the G-T mismatch is not recognized by BER, MMR could function as a 
back-up mechanism.  
 
Ogg1 in replication and transcription 
The transcription rate was as ineffective for OGG1 deficient cells as for CSB deficient 
cells, while the replication rate in the mutants did not differ compared to wild-type. The 
blocking potential of 8-oxoG is debated but the lesions is generally believed not to cause 
a block for the polymerase (Tornaletti 2005). A plasmid model demonstrate a 
transcription blocking potential of 8-oxoG in cells with functional BER (Kitsera et al. 
2011). The excision of 8-oxoG by OGG1 leads to the generation of a single-strand break 
which in turn blocks the RNA polymerase II. CSB is known to improve gene expression 
in the presence of single-strand breaks (Khobta et al. 2010). According to our hypothesis 
of CSB working downstream of OGG1 in BER, the repair intermediates from oxidative 
lesions probably have a higher blocking potential than 8-oxoG.  
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OGG1 and metabolism 
According to the aging theory, oxidative damage manifest into mitochondrial dysfunction 
and disease. We describe a novel ROS mediated regulation of the TCA cycle by the 
OGG1 mtDNA repair enzyme. The reversible inactivation of Aconitase connotes the 
importance of blocking the TCA cycle under conditions of superoxide anion stress. 
Reactivation of Aconitase is dependent on the mtDNA repair enzyme OGG1, and 
correlates with its repair function. We find that inactivated Aconitase is depleted in the 
absence of OGG1, which supports a role of OGG1 as a scaffold protein to facilitate 
enzymatic recovery and protection against degradation, as has been suggested (Panduri et 
al. 2009).  
mtDNA damage repair of OGG1 is additionally shown to be important for the 
differentiation potential of neuronal stem cells. Accumulation of mtDNA damage in 
OGG1 deficient stem cells contributes to a shift towards astrocytic lineage which may be 
related to redox condition and SIRT1 activation in neural stem cells (Prozorovski et al. 
2008) (Wei et al. 2011 in press).  The redox ratio, which is a key regulator of SIRT1, is 
influenced by mitochondrial activity thus, the underlying mechanism for how mtDNA 
damage influence the differentiation in stem cells might be influenced by how 
mitochondrial alterations in NADH/NAD ratio regulate SIRT1 (Wei et al. 2011 in press).  
 
mtDNA mutations in aging and disease 
mtDNA mutations are associated with aging and disease. The POLγ mouse with an 
elevated level of mutations show reduced lifespan and -related phenotypes, supporting 
the mitochondrial theory of aging. However, in the mouse deficient in MYH and OGG1 
no elevated levels of mutations were found (PAPER IV). This mouse also shows reduced 
lifespan in addition to cancer development (Xie et al. 2004). The oxidative damage load 
is high in tissue from myh-/-/ogg1-/- (Russo et al. 2004) and E.coli with deficiency in the 
same DNA repair genes demonstrate a strong mutation frequency (Michaels and Miller 
1992). As we could not find mutations in the mouse deficient in oxidative mtDNA repair 
our results ( PAPER IV) support the theory of mutations arising primarily from 
replication errors (Zheng et al. 2006) rather than from unrepaired damage.  More research 
is required in this field to elucidate how mutations emerge and how the mutation level in 
mtDNA is related to aging and disease.  
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CONCLUSION 
In conclusion, the use of CSB and OGG1deficient cells enable us to evaluate the impact 
of mtDNA damage on mitochondrial function and cellular homeostasis. Since these 
proteins are involved in mtDNA repair, it is expected that at least some of the phenotypes 
of the csbm/m and ogg1-/- mutants would be representative under conditions that are 
associated with increased mtDNA damage, like during disease and aging.  
Our observations contribute to unravel apparent DNA-unrelated factors that may be 
involved in metabolizing mtDNA. The facts that csbm/m cells display altered organization 
of the respiratory complexes in the inner mitochondrial membrane (PAPER I), is one 
example of such unexpected correlation between ETC and mtDNA maintenance. 
Furthermore, the regulation of citric acid cycle by OGG1, via mtDNA integrity 
dependent recovery of Aconitase (PAPER II), is another example for how mtDNA 
damage alters mitochondrial function.  
Surprisingly, we do not find experimental evidence to support that mtDNA damage can 
generate mutations, even in the double mutant myh-/-/ogg1-/- (PAPER IV). We believe 
that the existence of back-up mechanisms prevent unrepaired damages from being fixed 
into mutations. Further experiments with exposure to exogenous agents will unravel 
whether these back-up mechanisms are sufficient to prevent oxidant induced 
mutagenesis.  
We believe the cellular effects of mtDNA damage are best visualized by its ability to 
inhibit mitochondrial transcription (PAPER II). Upon oxidative stress, mitochondria 
undergo temporary inhibition of transcription and replication. However, the cell 
sensitivity correlates best with the selective suppression of transcription. Moreover, 
mtDNA damage mediates global regulation of replication and transcription processes. 
Further work is required to identify how these processes are controlled by mtDNA 
integrity.  
It is interesting to note that regardless of oxidants, mtDNA damage by itself is less toxic 
to the cell than repair intermediates that accumulate in mutants or maybe under excessive 
mtDNA repair initiation.   
 
 
34 
 
FUTURE PERSPECTIVES 
Future work will include biological characterization of CSB’s role in mtDNA repair and 
transcription. In this respect, recombinant proteins are available with mutations in the 
ATpase and helicase domains in CSB. These domains have been shown to be essential 
for specific cellular function of CSB.  
Efforts to distinguish transcribed mtDNA from replicated mtDNA could potentially be 
used to evaluate specific roles of CSB in either process. It should be mentioned in this 
respect that CSB has now been shown to interact with the mitochondrial RNA 
polymerase (Vilhelm Bohr, personal communication), in support of our data.  
Does mtDAN base damage cause mutation or arrest? Data collected and reported so far 
suggest that misincorporation by POLγ appears to be more important for mtDNA 
mutagenesis than premutagenic base lesions. CSB is involved in preserving 
mitochondrial function, and may play a role in preserving mtDNA integrity during 
replication and/or transcription. Perhaps future studies will identify a role of CSB in 
transcription coupled repair of mtDNA? 
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Abstract 
Reactive oxygen species (ROS) are formed as natural byproducts during aerobic metabolism and 
readily form premutagenic base lesions in the DNA. The 8-oxoguanine DNA glycosylase 
(OGG1) and MutY homologue 1 (MYH1) synergistically prevent mutagenesis and cancer 
formation in mice. The mitochondrial localization of the OGG1 and MYH1 DNA glycosylases 
suggests that mutations in mitochondrial DNA (mtDNA) could play a significant role in the 
pathology of the myh-/-/ogg1-/- double knockout mouse. As mtDNA mutations are frequently 
detected in various cancer cells, we hypothesized mtDNA mutations could result in 
mitochondrial dysfunction that is responsible for the carcinogenesis in these mice.  
In order to test this hypothesis, we analyzed mtDNA mutagenesis and mitochondrial function in 
young (1 month) and adult (6 months) wt and myh-/-/ogg1-/- mice. To our surprise, the absence of 
OGG1 and MYH did not increase mtDNA mutations, even at the onset of cancer. This shows 
that mtDNA mutagenesis is not responsible for the carcinogenesis of these mice. In line with 
these results, age-matched mitochondria from the cancerous tissues liver and lung displayed 
similar respiration characteristics in wt and myh-/-/ogg1-/- mice, whereas a significant reduction 
was observed in brain mitochondria from the adult myh-/-/ogg1-/- mouse.  Biochemical analyses 
confirmed these results as there was no difference between wt and myh-/-/ogg1-/- mitochondria 
with respect to complex I and V activities in liver and lung mitochondria, but complex I activity 
in brain mitochondria was reduced by 25 % in the adult myh-/-/ogg1-/- double knockout mice. 
Our results demonstrate that mtDNA mutations are not responsible for the pathology of myh-/-
/ogg1-/- mice, and the reduced mitochondrial function in brain mitochondria is probably due to 
nuclear DNA mutations in these mice. Furthermore, our results show that OGG1 and MYH are 
not important for protecting mtDNA against spontaneously induced mutations.   
 
 
 
 
 
Introduction 
DNA mutations, either induced by exogenous agents or spontaneously formed, are responsible 
for cancer. Mutations in nuclear tumor suppressors or protooncogenes predispose to cancer 
development. The impact of mitochondrial (dys)function on tumor biology is illustrated by the 
dependence of aerobic glycolysis, first observed by Warburg (1). Tumor-promoting suppression 
of citric acid cycle and as well as tumordependent utilization of anabolic pathways can be 
supported by mutations in the protooncogene succinate dehydrogenase and increased expression 
of specific isoforms of pyruvate kinase and hexokinase (2;3). The oxidative degradation of 
metabolites generates reducing equivalents that drives the electron transport chain (ETC) in the 
inner mitochondrial membrane, which is important for cell signaling, apoptosis control, 
membrane potential and ATP production; all central processes in cancer cell biology. The ETC 
are composed of five different complexes where complex I is the largest and consists of 45 
subunits. In addition to the catalytic subunits of complexes, assembly factors, chaperone proteins 
and lipids are involved in the stabilization and organization of ETC complexes in the inner 
mitochondrial membrane (4;5). The mtDNA encodes 13 essential subunits of the ETC, and 
mutations in mtDNA are associated with disease, neurodegeneration, aging and cancer (6-8). The 
effect of mtDNA mutations has shown to be mediated by increased ROS production (9) and it 
has been shown that the mitochondria pool determines the cancer phenotype (9; 10).  
Mutations arise from premutagenic lesions, such as 7, 8-dihydro-8-oxoguanine (8-oxoG) as this 
lesion readily mispairs with adenine during DNA replication. The cellular defense to combat 8-
oxoG-induced mutagenesis lesions includes the following evolutionary conserved functions: 1) 
the Fpg/OGG1 DNA glycosylase, which removes premutagenic 8-oxoG from DNA opposite 
cytosine (11), 2) MutY DNA glycosylases which removes misincorporated adenine opposite 8-
oxoG or G (12), and 3) MutT Nudix hydrolases which hydrolyze 8-oxoGTP to prevent 
incorporation into the DNA (13). The combined action of Fpg and MutY type of proteins reduce 
the mutagenic potential of 8-oxoG in E. coli by more than 100 times (14). While the cancer 
prone phenotypes of the single knockouts ogg1-/- and myh-/- are mild, the myh-/-/ogg1-/- double 
knockout mouse display strong tumorigenesis with severe effect on lifespan (15). More 
specifically, the double knockout mice have a lifespan expectancy of LD50 about six months. 
The frequencies of lung and liver carcinomas are increased in these mice, and correlates with 
age-dependent accumulation of 8-oxoG in the nuclear DNA from liver and lung, but not in brain 
(16). No tumors were identified in the brain from these animals, an observation that correlates 
with stable levels of the 8-oxoG with age. The tumorigenic capacity of the 8-oxoG:adenine 
mispairing event was supported by the fact that the majority of the tumors carry G-T transversion 
mutations in the k-RAS oncogene (16). 
Besides being important for nuclear DNA stability, the OGG1 and MYH proteins are 
additionally located in mitochondria. Mitochondrial 8-oxoG accumulates readily in liver mtDNA 
from ogg1-/- single knockout mice (17). Thus, it is expected that the myh-/-/ogg1-/- double 
deficient mouse would suffer from increased mtDNA mutagenesis, which may contribute to and 
even be responsible for the cancer phenotype of the myh-/-/ogg1-/- double knockout mice. 
Mutations in the mtDNA are associated with premature aging, and the lifespan of the myh-/-
/ogg1-/- mouse is similar to that of the mitochondrial mutator mouse generated by Trifunovic and 
coworkers (16;18), although the phenotypes are different.  
Here, we evaluated the mtDNA integrity in different tissues from the OGG1/MYH double 
deficient mouse and correlated these findings with mitochondrial function, assessed by 
respiration characterization and biochemical analyses of ETC complexes. Our results 
unexpectedly show that spontaneous mtDNA mutagenesis is independent OGG1 and MYH and 
that mitochondrial alteration does not contribute to the cancer phenotype of these mice. 
Furthermore, the absence of mtDNA mutagenesis suggests that nuclear DNA mutations are 
responsible for the mitochondrial dysfunction in brain from the myh-/-/ogg1-/- mouse. 
 
Materials and Methods 
Mice strains, mitochondria and materials 
The c57 BI/6:myh-/-/ogg1-/- double knockout mouse has been generated previously (15) and was 
kindly provided by Dr.T.Lindahl (Clare Hall Laboratories, Cancer Research UK London 
Research Institute, South Mimms, Herts, UK). Wt c57 Bl/6 was bred inhouse in the same room. 
Animals were bred in accordance with European regulations FELASA category C. The 
genotypes of the mice were routinely tested by a PCR-based protocol upon tissue collection; Fig. 
S1. Liver DNA from 35 weeks old mice expressing proof-reading deficient DNA polymerase  
in one (polgmut/+) or both alleles (polg mut/mut) was obtained from Nils-Göran Larsson, Max-
Planck Institute, Germany. 
Liver, lung and brain tissue were harvested from young (1 month) and adult (6 months) wt and 
ogg1-/-/myh-/- double knockout mice and homogenized in MSHE buffer (19) using potter-
elvehjem homogenizer. Samples were collected for DNA isolation and stored at -20°C. The 
remaining homogenate was used for preparation of mitochondria, using the method of Croteau et 
al (19), except that the gradient purification step was omitted.  
All chemicals and enzymes were obtained from SIGMA unless otherwise specified. 
Quantification of mtDNA damage 
Total DNA was isolated from tissue homogenates using a DNA purification kit (“DNeasy Blood 
& Tissue Kit” cat. # 69506; Qiagen). mtDNA damage was quantified by the ability of selectively 
inhibit amplification of a large PCR product over a small PCR product (20) and modified slightly 
as described in Osenbroch et al. (21).  
Quantification of mtDNA mutations  
Random Mutation Capture assay (RMC) 
Mutations were quantified using the RMC method developed by Vermulst et al (22) with the 
following modifications: Total DNA was digested both with S1 nuclease (10 U per DNA sample 
in 50 μl containing S1 buffer, 15 min 60°C) to remove single stranded DNA that otherwise 
escapes Taq1 digestion and consequentially results in artificially high level of mutation rate 
unless excessive amounts of TaqI is used. Taq1 digestion mixture contained 100 U Taq1 (New 
England Biolabs) in 50 μl with 1xBSA and was incubated for 10 hours at 60°C and subsequently 
inactivated at 95ºC. Serial dilutions of each DNA preparation were made to estimate mtDNA 
copy number. The RMC was then applied on 10 000 copies of mtDNA in 96 well plates. To 
eliminate possible contamination and ensure complete digestion, 1 U Taq1 was added to the 
qPCR mix. Real-time qPCR was used to detect positive mutants in a reaction mixture (20 μl) 
containing DNA, SYBRGreen buffer, 1 U Taq1, 0.5 pmol sense and antisense primers spanning 
the TaqI site at position 634 (22). To distinguish positive PCR products from artificial qPCR 
signals (e.g. primer-dimer), any signal with CT <34 was regarded as positive. 
Real-time analysis of mutation frequency (RAMF)  
We developed a faster, real-time based method for quantification of mtDNA mutation frequency. 
A similar procedure was recently reported by others (23), except that we included use of S1 
DNA nuclease and performed qPCR analysis as described above. In brief, total DNA (6 ng) was 
either untreated, or digested with S1/Taq1 as illustrated above, and the resulting ct (ct value for 
digested DNA minus ct for nondigested DNA) estimated. Mutation frequency per bp is given by 
the formula: (1/ (2exp (ct))/4.  
Biochemical mitochondrial complex activity 
Complex I activity measurements was performed as described by Brooks and Krähenbühl (24) in 
a 96 well plate reader (Wallac) in the absorbance range 355 (+/-25) nm. Complex V activity was 
measured as described in Barrientos et al and Yu et al (26;27). In brief, the mitochondrial 
proteins were diluted to 40 μg in 20 μl dH2O. 150 μl complex V buffer (50 mM Tris HCl pH 8.0, 
2mM ATP, 0,3 mM NADH, 2 mM MgCl2, 3 mM Phosphoenolpyruvate, 5 U/ml lactate 
dehydrogenase, 2,5 U/ml Pyruvate kinase and 2 μg/ml Antimycin A) was added to each well and 
the plate was measured immediately at 340 nm using the Wallac for 5 min every 30 sec (kinetic 
program). Oligomycin (50 μg/ml) was added instead of Antimycin A as control. The ATPase 
activity was measured by the steady decrease in NADH absorbance (355 (+/-25) nm).  
Mitochondrial respiration analyses 
Respiration characterization of isolated mitochondria was performed using an oxygraph-2K with 
the integrated software DATLAB 4.2 (Oroboros Instruments). The stirrer speed was set to 750 
r.p.m.. Approximately 50-100 μg mitochondria were used in Mir05 buffer (27). Complex I-
supported respiration was initiated by pyruvate (5 mM) and  malate (2 mM). Rate III respiration 
was induced by adding ADP (2 mM). Complex II-based respiration was determined after 
inactivating complex I by rotenone (0.5 μM), followed by succinate (10 mM) supplementation.  
Statistics 
Each group consists of 5 mice. Unless otherwise stated, average values with SD are shown. 
Statistical significance is calculated using students t-test. 
 
 
 
Results 
We used a PCR based method to evaluate mtDNA damage in brain, liver and lung tissues from 
the myh-/-/ogg1-/- double knockout mouse. Quantification of mtDNA damage is based on the 
ability to inhibit amplification of a large DNA fragment (20). 8-oxoG has been shown to 
accumulate markedly in nuclear DNA after 4 months in liver and lung from the myh-/-/ogg1-/- 
double knockout mouse (16). In order to evaluate the timing of potential damage accumulation in 
mtDNA, we compared mtDNA from wt and double knockout mice at the age of1 and 6 months. 
The latter age corresponds to the onset of tumor development in the mutant mice (15). In young 
animals (1 months), there was no significant effect of OGG1 and MYH deficiency on the 
mtDNA integrity in liver, lung or brain tissue, as measured by this method (Fig. 1). Since this 
mtDNA damage detection method scores for the ability of a lesion to block DNA polymerase in 
a PCR reaction, the results either imply that there is negligible mtDNA damage accumulation in 
myh-/-/ogg1-/- mice, or alternatively that the accumulated lesions, such as 8-oxoG, are readily 
bypassed by the PCR DNA polymerase. In adult mice, the integrity of mtDNA from lung and 
brain was similar (Fig. 1B and C), while liver mtDNA from the myh-/-/ogg1-/- double knockout 
mice surprisingly scored for less mtDNA damage compared to the age-matched wt mice (Fig. 
1A). We conclude that the combined deficiency of OGG1 and MYH do not result in 
accumulation of blocking lesions or strand breaks in mtDNA.  
The apparent reduction in mtDNA integrity in wt mtDNA (Fig. 1A) could be indicative of repair 
intermediates, such as single strand breaks, which are readily detected by the mtDNA damage 
assay. 8-oxoG satisfies the criteria for a lesion that is readily bypassed by DNA polymerases in 
the myh-/-/ogg1-/- double knockout mice. To evaluate the consequence on mtDNA mutagenesis, 
we employed two distinct methods where both scores for the ability of a mutation to destroy a 
TaqI restriction enzyme recognition site (TCGA). The restriction enzyme site is located at 
position 634 in mtDNA, in the 16 S ribosomal gene. First, the two methods were compared by 
measuring mutation rates in liver mtDNA from wt mouse (4 weeks) and in liver mtDNA from 
mice expressing proofreading deficient DNA polymerase  from one and both alleles, 
respectively. The Random Mutation Capture (RMC) mutation method was developed by 
Vermulst and coworkers and requires amplification of a single copy of mutated mtDNA (22), 
and were modified slightly by us to reduce background noise due to single-stranded regions of 
mtDNA (see materials and methods). Compared to wt mice, the mtDNA mutation rates in the 
polgmut/+ and polg mut/mut controls were 10 and 60-fold increased, respectively. The mutation rates 
for wt liver mtDNA is in the range previously reported for heart and brain mtDNA, using this 
method (22), but the rates for the mutant mice are lower. We developed another real-time based 
analysis of mutation frequency (RAMF) method, which is less sensitive to PCR contamination 
and less cost and time expensive (see Materials and Methods). During the progression of our 
work, a similar technology was reported (23). The RAMF method yielded 16- and 60-fold 
increase in mtDNA mutation rates from the polgmut/+ and polg mut/mut mice, respectively, 
compared to wt (Table 1). Overall, our RAMF method gave slightly elevated mutation rates 
compared to RMC (approximately 2-fold). 
We then quantified the mutation rates in mtDNA from wt and myh-/-/ogg1-/- double knockout 
mice by the two methods. To our surprise, the absence of OGG1 and MYH did not result in 
increased mtDNA mutation rates in any tissue, either in young or adult animals (Table 2 and 3). 
There were no differences in mutation rates between the two different age groups, but the 
mutation rates varied between the tissues. While lung mtDNA was found to suffer from most 
mutations (5 fold) as judged by the RMC method (Table 2), the RAMF method identified highest 
mutation rates in liver mtDNA (Table 3). We used the same DNA for both methods hence we 
believe the reason for the discrepancy is due to tissue-dependent variations in the mtDNA. It is 
important to note that the difference in absolute frequencies vary similarly in a method-
dependent manner between the different tissues and genotypes (Table 2 and 3). In conclusion, 
using either RMC or RAMF methods, the mutation rates in liver, lung and brain mtDNA from wt 
and myh-/-/ogg1-/- double knockout mouse are similar, independent of age. 
The innocuous effect of deleting MYH and OGG1 on mtDNA mutagenesis is surprising in view 
of the evolutionary conserved role of these functions for protection against mutagenesis. Since 
the mutagenesis assay does not score for functionality, it was a possibility that the mutagenesis 
assay scored for a subpopulation of mtDNA that is specifically protected from mutagenesis or 
alternatively escapes detection because only one area of mtDNA is investigated. In order to 
follow up on this point, we evaluated the functionality of isolated mitochondria by respiration 
characterization. The respiration characteristics were similar for mitochondria from young wt 
and myh-/-/ogg1-/- mice, regardless of whether complex I or II was supporting respiration (Fig. 2). 
In the adult mice, lung and liver mitochondria displayed similar respiration efficiency in wt and 
myh-/-/ogg1-/- mice. In contrast, we observed a small but significant reduction of respiration 
efficiency in brain mitochondria during complex I and II-utilization (Fig. 2C). This shows that 
the OGG1 and MYH double deficiency is manifested as a mitochondrial dysfunction in brain at 
6 months age. 
It was possible that potential ETC dysfunction could be masked by the lower respiration capacity 
compared to ETC capacity. In order to evaluate the maximal capacity of the ETC, we measured 
biochemical activity of complex I and V in the different tissues of the two age groups. For 
complex I, a significant decrease in activity (approximately 25 %) was found in brain 
mitochondria from 6 months old myh-/-/ogg1-/- double knockout mice (Fig. 3A), and suggests that 
complex I insufficiency at least partially contributes to the lower respiration efficiency in Fig. 2. 
Except for brain mitochondria from adult mice, there were no significant differences between wt 
and mutant mitochondria from other tissues (Fig 3A). When complex V was analyzed, we found 
no significant difference between wt and myh-/-/ogg1-/- mitochondria, regardless of tissue and age 
(Fig. 3C). Thus, in conclusion, our functional evaluation of mitochondria from liver and lung 
tissue fail to demonstrate any correlation between mtDNA repair capacity exerted by 
OGG1/MYH and mitochondrial function. The reduced mitochondrial activity in brain 
mitochondria from the adult double knockout mice does not correlate with mtDNA mutagenesis 
and thus may indicate that nuclear mutagenesis contributes to the mitochondrial dysfunction in 
these mice.    
 
Discussion 
In this study, we have investigated the impact of OGG1 and MYH on mtDNA mutagenesis. To 
our surprise, the combined deficiency did not result in increased mutagenesis despite that both 
proteins are localized to the mitochondria. These findings were confirmed by functional assays 
of mitochondria from lung and liver which displayed similar biochemical and respiration 
activities as the age-matched wt mice. The cancer prone phenotype of the animals is therefore 
not due to mitochondrial alterations. 
OGG1 has previously been shown to be essential for efficient removal of 8-oxoG from liver 
mtDNA (17). Thus, the additional removal of MYH was expected to increase the mutagenic 
potential of accumulated 8-oxoG. We believe the explanation for the innocuous effect of 
removing OGG1 and MYH in mtDNA is due to efficient backup systems in the mitochondria. 
Members of the NEIL family of DNA glycosylases have substrate specificities that overlap with 
that of OGG1. For instance, NEIL1 excises 8-oxoG and has been identified in mitochondria (28). 
NEIL2 is another 8-oxoG removing enzyme that additionally has been implicated in mtDNA 
repair (Hazra, personal communication). For the premutagenic 8-oxoG:A basepair, it is possible 
that this could be handled by the mismatch repair shown to be present in mitochondria (29; 30).  
Our findings demonstrate that OGG1 and MYH are indispensible for protection against mtDNA 
mutations in lung, liver and brain tissue. In Fig. 1, we show that the ability to amplify a 10 kb 
large fragment from liver mtDNA was 2-fold higher when using template from adult double 
mutant mice compared to wt mice. If the reason for the decreased PCR efficiency in wt mice is 
due to ongoing repair of 8-oxoG, it can be calculated that repair frequency is 0.7 per mtDNA, 
using the poisson distribution model (20). Interestingly, this repair incidence is close to the 
estimated steady state level of 8-oxoG in liver mtDNA from ogg1-/- single knockout mouse (19). 
Thus, our results suggest that induced 8-oxoG is rapidly recognized and removed by OGG1 in 
wt. In OGG1 deficient mitochondria, backup mechanisms that either omit strand breaks or 
alternatively proceed with faster repair rates (to fast for being detected by the mtDNA damage 
method) prevent progressive accumulation of 8-oxoG and subsequent mutagenesis. During 
oxidative stress, ring-opened purines (such as formamidopyrimidines; faPy) are formed in 
addition to 8-oxoG and presumably accumulates in myh-/-/ogg1-/- mice since these lesions are 
substrates for OGG1 (31). The faPy residues can block DNA synthesis (32). Thus, it is also 
possible that apparent lack of mtDNA damage accumulation is due to a combined ability of PCR 
DNA polymerase to bypass 8-oxoG and being blocked by faPy in the mutant mice, and ability to 
amplify repaired mtDNA and being blocked by repair intermediates in the wt mice.  
The double deficient mice were previously analyzed for nuclear DNA 8-oxoG, where the authors 
discovered a correlation between age-dependent accumulation of 8-oxoG and cancer incidence in 
different tissues (16). Interestingly, brains from the myh-/-/ogg1-/- double knockout mice were 
found to be spared for age-dependent accumulation of 8-oxoG, which also correlated with the 
lack of tumors in this tissue. Since brain has a high metabolic rate, it is nevertheless expected 
that the frequency of spontaneously formed lesion exerts a detrimental pressure. Thus, backup 
DNA nuclear repair mechanisms appear to be a plausible mechanism for the relative low damage 
accumulation in brain from these animals. Our results, however, indicate that mitochondrial 
dysfunction observed in adult brain from the myh-/-/ogg1-/- double knockout mice is due to 
nuclear mutagenesis, since the mutation rate is similar in wt and mutant mtDNA. One 
explanation could be that regional accumulation of damage in promoter region of genes in the 
brain could suppress expression of mitochondrial proteins encoded by nucleus. Such regional 
localization of damage has been identified previously in brain tissue during aging (33).  
Here we used mutation-mediated inhibition of TaqI digestion as tool to quantify mtDNA 
mutagenesis. By focusing on the TaqI site at position 634, there is a possibility that mutations 
accumulate outside elsewhere in the mtDNA and escape detection. In particular, the mtDNA 
region spanning from nt 15.423 to 16.299 region has been found associated with low mutation 
rates (Jim Steward, personal communication). Since clonal expansions might contribute to 
increase the impact of mutations outside this area, we cannot exclude the possibility that 
subregions of mtDNA from the myh-/-/ogg1-/- double knockouts suffer from elevated mutagenesis 
that alter cancer susceptibility. However, the lack of correlation between mitochondrial 
dysfunction found here and the reported cancer disposition do not favor this possibility. Vermulst 
et al reported that TaqI sites at positions 7667, 12080 and 15253 displayed similar mutation 
characteristics with respect to frequency, age-dependence and type of mutations. The RMC 
method has been reported to be sensitive to artificial background (34). We include S1 nuclease to 
remove interacting single stranded DNA, which otherwise can induce unspecific PCR priming as 
well as escaping TaqI digestion and thereby result in false positive signals. 
In conclusion, our results show that the OGG1 and MYH DNA glycosylases are dispensable for 
protecting against mutations in mtDNA. Additional deletion of e.g. NEIL functions may provide 
more information about the extent that base lesions contribute to mtDNA mutagenesis, in 
comparison with misincorporation by DNA polymerase .  
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Figure legends 
Figure 1. mtDNA integrity in liver (A), lung (B) and brain (C) from wt and myh-/-/ogg1-/- double 
knockout mice of 1 and 6 months (mo) age, as indicated. Total DNA was isolated and analyzed 
for mtDNA damage by the ability to generate a large PCR product. Relative mtDNA integrity is 
presented relative to average of wt (1 mo) values. N=5, *p<0.05. 
 
Figure 2. Respiration characteristics of mitochondria from liver (A), lung (B) and brain (C), from 
1 and 6 months (mo) old wt and myh-/-/ogg1-/- double knockout mice. Mitochondria were isolated 
by differential centrifugation and transferred to an oxygraph-2K with the following serial 
manipulations: Initial complex I-dependent respiration was supported by pyruvate/malate (PM), 
followed by ADP addition to obtain state III respiration (ADP). Thereafter, rotenone (ROT) was 
added, to provide complex II-dependent respiration, supported by succinate (SUCC; 10 mM). wt: 
dark bars, myh-/-/ogg1-/- double knockout mice: grey bars. N=5; *p<0.05. 
 
Figure 3. Mitochondrial biochemical complex activities. A, NADH-oxidoreductase (complex I) 
and B, ATPase (complex V) activities in liver, lung and brain mitochondria were analyzed as 
described and presented as indicated in the figure. Average values of wt (black bars) and myh-/-
/ogg1-/- double knockout mice (grey bars) are provided with SD for mice, age 1 and 6 months 
(mo), as indicated. N=5, *p<0.05. 
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